Home page
|
Help
|
Clear
English
|
French
Search
|
Categories
|
Titles A-Z
|
Countries
|
Compare countries
|
Index
Full TOC
Expand Document
Expand Chapter
Preferences
Printable HTML version
Export document as HTML file
Help
Baseline Assessment of the Nigerian Pharmaceutical Sector
(WHO; 2002; 62 pages)
Acknowledgements
List of abbreviations
Executive summary
Introduction
Nigeria: Country Profile
THE HEALTH STATUS OF NIGERIANS
Under-Five Morbidity and Mortality Rates
BASIC HEALTH INDICATORS
Demographic Indicators
Socio-economic Indicators
Health Status Indicators
Morbidity indicators
Mortality Indicators
Structure of the health system in Nigeria
DRUG SECTOR ORGANISATION
The National Drug Policy
Essential Drugs List (EDL)
Legislation
Medicine financing
Pharmaceutical Research and Production
Rational Use of Medicines
Human Resources
INTRODUCTION TO THE STUDY
Study purpose and indicators
STUDY DESIGN AND METHODOLOGY
Scope and limitations
Sampling procedure
Training of Data Collectors and pre-testing of instruments
Data Collection
Analysis of Data
Problems experienced
RESULTS AND ANALYSIS ACCESS
Availability of key drugs
Expired drugs
Affordability
Household Survey
QUALITY AND SAFETY
Rational use of drugs indicators
Prescribing of Drugs
Patient Care
INTERPRETATION OF RESULTS
Access
Quality and Safety
Rational Use of Drugs
CONCLUSIONS AND RECOMMENDED INTERVENTIONS
Access and Quality
Rational Use of Drugs
ANNEX 1
Forms for Level I Indicators
ANNEX 2
Survey Forms for Level II Indicators
DRUG SECTOR ORGANISATION
Please provide your feedback
English |
French